NHS urged to retain Victorian frontage at new centre
NHS health bosses have been urged to preserve the historic frontage of a Hinckley hospital in its proposal for a new £10.5m medical facility.
The NHS Leicester, Leicestershire and Rutland Integrated Care Board plans to build the day case unit on the existing Hinckley and District Hospital, in Mount Road.
The leader of Hinckley and Bosworth Borough Council has now written a letter to the board expressing his "deep disappointment" the Victorian frontage will be demolished as part of the plans.
The board said it was unable to retain the frontage due to clinical requirements of the development but planned to include some materials from the current building.
The new facility is designed to deliver services including gynaecology, urology and plastic surgery and will be linked to the new community diagnostic centre at the site.
A planning application to demolish the entire hospital was submitted to the borough council earlier this month.
In his letter, council leader Stuart Bray said he "warmly" welcomed improved NHS facilities in the town following decades of campaigning but urged the board to "look at the plans again" and offered to hold discussions.
He wrote: "Having now seen the plans for the new day care centre, I want to express my deep disappointment that they include the demolition of the Victorian cottage hospital which has stood on Mount Road for centuries and is part of my hometown's heritage.
"I cannot believe it is not possible to retain the older parts of the frontage of the hospital and develop the new modern facilities that residents deserve, behind the Victorian facade.
"Many people have contacted me to express concerns over your plan. I know these concerns will not be new to you as I believe such concerns were raised as part of the public consultation."
In a statement the board said: "The option of retaining the Victorian frontage of the hospital unfortunately would have meant that the business care objectives and clinical requirements for the development of the new facilities would not be met.
"The proposed materials do include reclaimed bricks from the current building and we consider that the heritage impact of the scheme will be outweighed by the benefits to the public.
"We are also working with a local historian on plans to display images inside and outside of the new building, charting its long history."
A public consultation period is under way on the council's website and will run until 13 June.
Follow BBC Leicester on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@bbc.co.uk or via WhatsApp on 0808 100 2210.
Plans submitted to create £10.5m medical unit
Preparation work to begin for new hospital unit
Go-ahead for multi-million pound diagnostic centre
Hinckley and Bosworth Borough Council
NHS Leicester, Leicestershire and Rutland Integrated Care Board
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
If books could kill: The poison legacy lurking in libraries
The Victorians loved the colour green. In particular, they loved a vibrant shade of emerald created by combining copper and arsenic, which was used in everything from wallpaper to children's toys. "This colour was very popular for most of the 19th Century because of its vibrancy and its resistance to light fading," says Erica Kotze, a preservative conservator at the University of St Andrews. "We know that many household items were coloured with arsenic-based green pigments. It was even used in confectionery." The trouble is, the combination of elements used is toxic and that's still a problem more than a century later. And it's a particular problem when it comes to old books. Victorian bookbinders used arsenic as well as mercury and chrome to create striking covers. And unlike domestic items, books have survived in archives around the world, creating a 21st Century problem from 19th Century fashion. Prolonged exposure to multiple green books can cause low level arsenic poisoning. Long-term exposure can cause changes to the skin, harm to the liver and kidneys and a reduction in red and white blood cells, which can lead to anaemia and an increased risk of infections. In 2019, an attempt to tackle the problem was set up in Delaware between the Winterthur Museum and the state university. The Poison Book Project tested books and drew up a list of titles which are potentially harmful to humans. These included four books in the National Library of France, which were immediately withdrawn. Inspired by this, Erica Kotze called on her colleague Dr Pilar Gil, who trained as a biochemist before working in Special Collections at the University of St Andrews. Dr Gil took a practical approach to surveying the thousands of historic books in their collection. "The most important thing was to find a non-destructive, portable instrument that could tell us if it was a poisonous book or not," she says. She rule out X-ray technology because of the fragile nature of the books being examined and instead looked to the geology department. They had a spectrometer - a device that measures the distribution of different wavelengths of light - for detecting minerals in rocks. "Minerals and pigments are very similar," says Dr Gil, "so I borrowed the instrument and started looking for emerald green in books." She tested hundreds of books and then realised she was looking at a breakthrough. "I realised there was a distinctive pattern to the toxic ones. It was a 'eureka' moment. I realised it was something that no one had seen before." The next task was to speak to the physics department to build their own prototype. Dr Graham Bruce, senior research laboratory manager explains how it works. "It shines light on the book and measures the amount of light which shines back," he says. "It uses green light, which can be seen, and infrared, which can't be seen with our own eyes. The green light flashes when there are no fragments of arsenic present, the red light when there are pigments." The new testing device is smaller and will be less costly to produce and use than a full-scale spectrometer It has already been used to survey the thousands of books in the St Andrews collections and in the National Library of Scotland, and the team hope to share their design with other institutions around the world. "We're lucky as a large institution to have expensive kit, so that we can test 19th Century potentially toxic books," says Dr Jessica Burge, deputy director of library and museums at the University of St Andrews. "But other institutions with big collections may not have those resources, so we wanted to create something which was affordable and easy. It doesn't require a specialist conservator or analysis, and it's instant." It's also a problem which isn't going away. If anything, toxic books will become more harmful as they get older and disintegrate. Identifying them means they can stored in a safe way and still enjoyed with controlled access and precautions such as wearing gloves. "It will continue to be a live issue," says Dr Burge. "But I think that the biggest issue for institutions at the moment is that any book that's got a green cover from the 19th Century is being restricted because they don't know. "And as libraries and museums, that's not really what we're about. We want people to be able to use the books and help bring back access to collections, rather than restricting their use."
Yahoo
2 hours ago
- Yahoo
ADHD drugs back in the spotlight after study debunks rising prevalence
An increasing number of patients are seeking support for attention-deficit/hyperactivity disorder (ADHD), with pharmacological-based treatments an important part of medical care for the neurodevelopmental condition. A study published this week in the Journal of Affective Disorders has found that greater awareness and acceptance around the disorder has led to more people seeking help. The research, led by a team at King's College, London, debunks claims that the disorder is 'naturally' on the rise. The data comes as a national taskforce in England investigates what this rising demand for support means for the NHS. Figures published in May 2025 by NHS England estimated there were nearly 2.5 million people in England with ADHD. This includes more than 550,000 currently waiting for an assessment. Every month 20,000 more people are referred for support, a rise of 13% compared to last year. Pharmaceutical Technology looks at some of the current options in the UK and casts an eye ahead to what the future drug landscape might contain. The first choice for patients with ADHD is methylphenidate, which belongs to a class of drugs called central nervous system (CNS) stimulants. The drug, which works by blocking the reuptake of norepinephrine and dopamine, increases activity in the brain, including regions associated with attention and behaviour. It is known under the brand names Ritalin, manufactured by Novartis, and Johnson and Johnson's Concerta. There is also Equasym and Xenidate, among others. Lisdexamfetamine dimesylate is also used to treat patients with ADHD. Like methylphenidate, lisdexamfetamine is a CNS stimulant and acts as a norepinephrine and dopamine reuptake inhibitor (NDRI). This drug is known under the brand name, among others, as Elvanse and Vyvanse, both manufactured by Takeda. While stimulants are fast acting, with side effects felt soon after administration, non-stimulant drugs take longer, yet can offer an alternative if drugs like methylphenidate and lisdexamfetamine dimesylate do not work. While improving, access to pharmacological-based treatments is still impaired amid an ongoing global shortage that began in September 2023. Methylphenidate and lisdexamfetamine were primarily affected – the shortage arising due to a combination of manufacturing issues and increased global demand. A separate study published in The American Journal of Managed Care in March suggested that overdiagnosis of ADHD is fuelling the shortage of stimulation medications. One of the most advanced candidate drugs, and one with notable buzz surrounding it, is Axsome's Sunosi (solriamfetol). Sunosi, which is also an NDRI but not a conventional stimulant, met its primary endpoint in a Phase III trial (NCT05972044) earlier this year. The medication led to a 45% drop in ADHD symptoms. As measured by the Adult ADHD Investigator Symptom Rating Scale (AISRS), 150mg Sunosi dosed achieved average reductions from baseline of 17.7 points, compared to 14.3 points for placebo. Sunosi is already approved in the UK to treat excessive daytime sleepiness (EDS) in adults with narcolepsy, with or without cataplexy. Certain patients with obstructive sleep apnoea (OSA) are also eligible to take the medication. In 2022, Axsome paid $53m up front to acquire Sunosi from Jazz Pharmaceuticals. A drug with a recent approval extension in the US, though not the UK, was Supernus Pharmaceuticals' Qelbree (viloxazine extended-release capsules). The mechanism of action of Qelbree, though unclear, is thought to be through inhibiting the reuptake of norepinephrine. Originally approved for children in 2021, the FDA updated the drug's label in January this year to include adults. ADHD treatments were in the political crosshairs in the US recently. The disorder, along with autism, was singled out by the Trump administration for an 'over-utilisation of medication'. Pharmaceutical intervention remains a helpful part of managing the disorder, though it is part of a combination of treatments that also include coaching and lifestyle changes. "ADHD drugs back in the spotlight after study debunks rising prevalence" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Hospitals to get £2.6m for infrastructure upgrades
Several hospitals are set to get upgrades after Nottinghamshire Healthcare NHS Foundation Trust has secured government funding. Work will include improving fire safety systems, water infrastructure and electrical and energy systems at Rampton Hospital, The Wells Road Centre, Wathwood Hospital, Thorneywood Mount and Arnold Lodge Hospital. The improvements at the sites, which offer mental health and community services across the Midlands and South Yorkshire, are due to start in the summer with the aim of completing next spring. Nottinghamshire Healthcare NHS Foundation Trust, which runs the hospitals, said the funding would support urgent projects and create a better environment for patients. The £2,595,000 grant is part of a national project to improve NHS buildings and infrastructure in England. At Rampton High Secure Hospital and several others, it is hoped the money will allow a full upgrade of fire safety systems - including alarms, fire compartmentation and suppression technology. The Wells Road Centre in Mapperley, Nottingham, will benefit from the replacement of ageing machinery. While at Arnold Lodge, in Leicester, a specialist secure unit, the money will deliver electrical and energy system improvements. The trust said planning work was under way to ensure the disruption was minimal. Chief executive at the trust Ifti Majid said the funding was "fantastic news", adding: "It allows us to fast-track improvements that make our hospitals safer, greener and more welcoming places to receive care and to work." Alison Wyld, executive director of finance and estates, added: "By tackling our highest-risk infrastructure now, we're not only reducing future maintenance costs but also supporting the trust's net zero ambitions." Follow BBC Nottingham on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@ or via WhatsApp on 0808 100 2210. High-security hospital 'still needs to improve' Work begins on £12m endoscopy unit at city hospital Construction under way on new hospital theatre suite Photos show 'crumbling', abandoned hospital rooms Nottinghamshire Healthcare NHS Foundation Trust
